Influences of Vitamin A on Vaccine Immunogenicity and Efficacy.
Ontology highlight
ABSTRACT: Vitamin A deficiencies and insufficiencies are widespread in developing countries, and may be gaining prevalence in industrialized nations. To combat vitamin A deficiency (VAD), the World Health Organization (WHO) recommends high-dose vitamin A supplementation (VAS) in children 6-59 months of age in locations where VAD is endemic. This practice has significantly reduced all-cause death and diarrhea-related mortalities in children, and may have in some cases improved immune responses toward pediatric vaccines. However, VAS studies have yielded conflicting results, perhaps due to influences of baseline vitamin A levels on VAS efficacy, and due to cross-regulation between vitamin A and related nuclear hormones. Here we provide a brief review of previous pre-clinical and clinical data, showing
SUBMITTER: Penkert RR
PROVIDER: S-EPMC6651517 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA